Data / Form D filings / Romark Laboratories, L.C.
Romark Laboratories, L.C.: Form D filings
Romark Laboratories, L.C., a pharmaceuticals company in Tampa, FL, filed 10 Form D notices with the SEC between 2009 and 2016. The latest, on February 11, 2016, reports an offering of $40 million with nothing sold yet.
Find out what Romark Laboratories, L.C. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3000 BAYPORT DRIVE, SUITE 200, Tampa, FL, 33607
- Phone
- (813) 282-8544
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Florida
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1470263
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 11, 2016 | New notice | $40,000,000 | $0 | $40,000,000 | 0 | Yet to occur | sec.gov |
| Nov 19, 2014 | Amendment | $15,000,000 | $10,750,100 | $4,249,900 | 112 | May 27, 2014 | sec.gov |
| Jun 24, 2014 | New notice | $10,000,000 | $1,914,850 | $8,085,150 | 19 | May 27, 2014 | sec.gov |
| Jun 13, 2014 | Amendment | $14,999,520 | $14,999,520 | $0 | 107 | May 9, 2013 | sec.gov |
| May 16, 2013 | New notice | $10,000,000 | $150,000 | $9,850,000 | 1 | May 9, 2013 | sec.gov |
| Nov 18, 2011 | Amendment | $9,647,700 | $9,647,700 | $0 | 126 | Dec 10, 2010 | sec.gov |
| Jan 4, 2011 | Amendment | $35,000,000 | $23,111,817 | $11,888,183 | 155 | Aug 26, 2009 | sec.gov |
| Dec 21, 2010 | New notice | $7,000,000 | $88,900 | $6,911,100 | 2 | Dec 10, 2010 | sec.gov |
| Jan 26, 2010 | Amendment | $30,067,616 | $15,067,616 | $15,000,000 | 97 | Aug 26, 2009 | sec.gov |
| Aug 28, 2009 | New notice | $20,000,000 | $300,000 | $19,700,000 | 3 | Aug 26, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| W. Seymour Holt | Director | |
| Jean Francois Rossignol | Executive Officer, Director | |
| Brian E. Schnieders | Executive Officer | |
| W. Andrew Krusen, Jr. | Director | |
| Marc S. Ayers | Executive Officer, Director | |
| Celine E. Rossignol | Executive Officer |
Other pharmaceuticals companies in Florida that filed recently
- GOA Therapeutics Corp $300,000 · Nov 5, 2026
- DalCor Pharmaceuticals US, LLC $7 million · Aug 28, 2026
Every Form D from the week of Feb 8, 2016 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Romark Laboratories, L.C. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.